From http://projects.propublica.org/docdollars. © Copyright 2013 Pro Publica Inc.
Merck
Merck, based in Whitehouse Station, N.J., agreed to pay more than $650 million to resolve allegations that it didn't pay proper rebates to government health programs and illegally paid health care providers as inducements to prescribe the company's products. In 2011, the company also agreed to pay $950 million to settle criminal charges and civil allegations stemming from its promotion and marketing of the painkiller Vioxx
Merck’s 2012 report was expanded to include speaking, consulting, travel, meals, research, studies and educational items for doctors. But Merck no longer includes the number of events or speaker topics, and it combines expenditures for travel, meals and royalties into one category.
See all Merck payments, or visit Merck's transparency page.
Notable drugs
- Singulair (asthma, exercise-induced bronchoconstriction, allergies)
- Januvia (diabetes)
- Zetia (cholesterol)
- Vytorin (cholesterol)
- Cozaar/Hyzaar (hypertension, left ventricular hypertrophy, diabetic kidney disease)
- Janumet (diabetes)
- Isentress (HIV)
- Nasonex (allergies, nasal polyps)
- Fosamax (osteoporosis, paget's disease)
- Cancidas (fungal infections)
- Maxalt (migraine)
- NuvaRing (contraceptive)
- Propecia (male pattern hair loss)
Payment Reports
2009 July to Dec.
| Avg. Quarterly | Total | |
|---|---|---|
| Speaking | $4,703,136 | $9,406,273 |
| $4,703,136 | $9,406,273 |
2010 Jan. to Dec.
| Avg. Quarterly | Total | |
|---|---|---|
| Speaking | $5,091,361 | $20,365,446 |
| $5,091,361 | $20,365,446 |
2011 Jan. to Dec.
| Avg. Quarterly | Total | |
|---|---|---|
| Speaking | $6,778,993 | $27,115,970 |
| Adjustment | -$1,119 | -$4,475 |
| $6,777,874 | $27,111,495 |
2012 Jan. to Sept.
| Avg. Quarterly | Total | |
|---|---|---|
| Research | $45,748,403 | $137,245,208 |
| Speaking | $4,807,701 | $14,423,104 |
| Other | $3,023,285 | $9,069,855 |
| Consulting | $1,681,574 | $5,044,723 |
| Items, Gifts | $558,524 | $1,675,571 |
| Adjustment | -$1,833 | -$5,500 |
| $55,817,653 | $167,452,960 |
Total Payments by State
| State | Total |
|---|---|
| California | $22,828,351 |
| Florida | $19,083,824 |
| New York | $16,835,772 |
| Texas | $16,703,308 |
| Illinois | $13,557,758 |
| Pennsylvania | $10,189,123 |
| Ohio | $8,457,569 |
| North Carolina | $8,395,725 |
| Massachusetts | $6,675,378 |
| New Jersey | $6,351,612 |
| Utah | $5,597,736 |
| Washington | $5,524,462 |
| Maryland | $5,134,114 |
| Missouri | $5,043,620 |
| Colorado | $4,810,940 |
| Georgia | $4,781,285 |
| Michigan | $4,716,721 |
| Virginia | $4,412,915 |
| Indiana | $4,345,242 |
| Nebraska | $3,796,276 |
| Wisconsin | $3,481,336 |
| Tennessee | $3,385,236 |
| Alabama | $3,190,501 |
| Connecticut | $3,136,003 |
| Oregon | $2,854,730 |
| Minnesota | $2,851,347 |
| Arizona | $2,639,594 |
| Louisiana | $2,525,134 |
| South Carolina | $2,347,435 |
| Oklahoma | $2,323,066 |
| Kentucky | $2,314,435 |
| Kansas | $1,981,759 |
| Arkansas | $1,557,394 |
| Idaho | $1,457,782 |
| Puerto Rico | $1,191,204 |
| Iowa | $1,082,121 |
| New Mexico | $1,053,711 |
| Montana | $944,593 |
| Rhode Island | $875,492 |
| Mississippi | $845,826 |
| Maine | $828,928 |
| South Dakota | $706,789 |
| Nevada | $670,129 |
| West Virginia | $655,650 |
| District of Columbia | $538,193 |
| North Dakota | $377,596 |
| Delaware | $334,148 |
| Vermont | $329,023 |
| Hawaii | $294,441 |
| New Hampshire | $263,521 |
| Alaska | $48,973 |
| Wyoming | $5,330 |
| [Unknown State] | $2,727 |
What Companies Disclose
See which services pharmaceutical companies report paying health practitioners for.
Big Pharma’s Big Fines
Drug companies have paid billions to the Department of Justice to resolve allegations of health care fraud. See some of the biggest settlements.
